• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

2021 Updated Cochrane Review: Does Calcium Supplementation Reduce Blood Pressure?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Several studies have found a link between increased calcium levels and reduced blood pressure
  • In this update to a 2015 review, Cormick et al. (Cochrane Database of Systematic Reviews, 2021) assessed the efficacy and safety of calcium supplementation versus placebo/control for reducing blood pressure in normotensive people and for the prevention of primary hypertension

METHODS:

  • Update to a systematic review and meta-analysis
  • Inclusion criteria
    • Randomized and quasi-randomized controlled trials
    • Studies that included normotensive people and provided dietary calcium interventions such as
      • Supplementation (pills, tablets or sprinkle powder)
      • Food fortification
      • Placebo/control
  • Study design
    • GRADE criteria used to assess the certainty of evidence
  • Primary outcomes
    • Hypertension: BP ≥140/90 mmHg)
    • Blood pressure measures

RESULTS:

  • 20 trials (18 in meta-analysis) | 3512 participants (3140 in meta-analysis)
    • New trials included in update: 4
  • Calcium interventions had a significant reduction effect on systolic and diastolic blood pressure
    • Systolic
      • Mean difference (MD) ‐1.37 mmHg (95% CI, ‐2.08 to ‐0.66)
      • 3140 participants; 18 studies; high‐certainty evidence
    • Diastolic
      • MD ‐1.45 (95% CI, ‐2.23 to -0.67)
      • 3039 participants; 17 studies; high‐certainty evidence

Reduction Based on Age

  • <35 years
    • Systolic
      • MD ‐1.86 (95% CI, ‐3.45 to ‐0.27)
      • 452 participants; 8 studies; moderate‐certainty evidence
    • Diastolic
      • MD ‐2.50 (95% CI ‐4.22 to ‐0.79)
      • 351 participants; 7 studies; moderate‐certainty evidence
  • ≥35 years
    • Systolic
      • MD ‐0.97 (95% CI, ‐1.83 to ‐0.10)
      • 2688 participants; 10 studies; I2 = 0%, high‐certainty evidence
    • Diastolic
      • MD ‐0.59 (95% CI, ‐1.13 to ‐0.06)
      • 2688 participants; 10 studies; I2 = 0%, high‐certainty evidence

Reduction in Both Women and Men

  • Women
    • Systolic
      • MD ‐1.25 (95% CI, ‐2.53 to 0.03)
      • 1915 participants; 8 studies; high‐certainty evidence
    • Diastolic
      • MD ‐1.04 (95% CI, ‐1.86 to ‐0.22)
      • 1915 participants; 8 studies; high‐certainty evidence
  • Men
    • Systolic
      • MD ‐2.14 (95% CI, ‐3.71 to ‐0.59)
      • 507 participants; 5 studies; moderate‐certainty evidence
    • Diastolic
      • MD ‐1.99 (95% CI, ‐3.25 to ‐0.74)
      • 507 participants; 5 studies; moderate‐certainty evidence

Effect On Blood Pressure More Pronounced with Higher Calcium Doses

  • Low doses (<1000 mg)
    • Systolic
      • MD ‐0.02 (95% CI, ‐2.23 to 2.20)
      • 302 participants; 3 studies; moderate‐certainty evidence
    • Diastolic
      • MD ‐0.41(95% CI, ‐2.07 to 1.25)
      • 201 participants; 2 studies; moderate‐certainty evidence
  • Intermediate doses (1000 to 1500 mg)
    • Systolic
      • MD ‐1.05 (95% CI, ‐1.91 to ‐0.19)
      • 2488 participants; 9 studies; high‐certainty evidence
    • Diastolic
      • MD ‐2.03 (95% CI, ‐3.44 to ‐0.62)
      • 1017 participants; 8 studies; high‐certainty evidence
  • Higher doses (>1500 mg)
    • Systolic
      • MD ‐2.79 (95% CI, ‐4.71 to -0.86)
      • 350 participants; 7 studies = 8; moderate‐certainty evidence
    • Diastolic
      • MD ‐1.35 (95% CI, ‐2.75 to ‐0.05)
      • 1821 participants; 8 studies; high‐certainty evidence
  • None of the studies reported adverse events

CONCLUSION:

  • Increasing calcium intake through supplementation or dietary fortification produces small reductions in systolic and diastolic blood pressure in normotensive people
    • This effect is particularly pronounced in younger people and varies with calcium dose

The authors state

The effect was confirmed in multiple prespecified subgroups, including a possible dose-response effect, reinforcing the efficacy of the intervention

The effects can be observed after only 3.5 months of intervention

Although the effect is small, an adequate calcium intake should be an objective to be reached in the general population

Randomised controlled trials (RCT) are needed with high power in the early stages of life

Learn More – Primary Sources:

Calcium supplementation for prevention of primary hypertension

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Do Vitamin D and Calcium Supplements Decrease Cancer Risk?
Are Dietary Supplements Associated with Decreased Mortality?
Does Combined Vitamin D and Calcium Supplementation Reduce Risk of Fracture?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site